Oncimmune Holdings (GB:ONC) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Oncimmune Holdings has successfully raised approximately £2.3 million following the approval of resolutions at a recent General Meeting. The company has initiated the trading of additional ordinary shares on AIM, increasing its total shares in issue to over 111 million. This strategic move aims to bolster Oncimmune’s financial standing and support its efforts in precision medicine research.
For further insights into GB:ONC stock, check out TipRanks’ Stock Analysis page.
